121 related articles for article (PubMed ID: 20686879)
1. The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer.
Minamiya Y; Miura M; Hinai Y; Saito H; Ito M; Imai K; Ono T; Motoyama S; Ogawa J
Tumour Biol; 2010 Dec; 31(6):673-9. PubMed ID: 20686879
[TBL] [Abstract][Full Text] [Related]
2. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.
Motoyama S; Mori K; Kamei T; Miura M; Hinai Y; Sato Y; Yoshino K; Sasaki T; Miyata G; Seto Y; Ogawa J
Ann Surg Oncol; 2013 Jun; 20(6):1978-84. PubMed ID: 23212764
[TBL] [Abstract][Full Text] [Related]
4. CRP 1846C>T Genetic Polymorphism Is Associated with Lymph Node Metastasis and/or Severe Lymphatic Invasion in Endometrial Cancer.
Kito M; Motoyama S; Fujita K; Miura M; Nanjo H; Sato N; Shimizu D; Sato T; Makino K; Sugawara T; Kato A; Tamura D; Takahashi K; Kumazawa Y; Sato W; Miura H; Shirasawa H; Sato A; Kumagai J; Terada Y
Tohoku J Exp Med; 2015 Sep; 237(1):25-30. PubMed ID: 26310275
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the potential for lymph node metastasis using CRP 1846C>T genetic polymorphism in invasive breast cancer.
Terata K; Motoyama S; Kamata S; Hinai Y; Miura M; Sato Y; Yoshino K; Ito A; Imai K; Saito H; Minamiya Y
Tumour Biol; 2014 Jun; 35(6):5931-5. PubMed ID: 24633920
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein gene 1846C>T polymorphism is associated with increased risk and clinical features of lung cancer: a case-control study.
Chen C; Liu JN; Zhao JQ; Zang B
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142628
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 29T>C genetic polymorphism is associated with lymph node metastasis in patients with adenocarcinoma of the lung.
Minamiya Y; Miura M; Hinai Y; Saito H; Ito M; Ono T; Toda H; Motoyama S; Ogawa J
Tumour Biol; 2010 Oct; 31(5):437-41. PubMed ID: 20506050
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
9. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
Goto I; Yoneda S; Yamamoto M; Kawajiri K
Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
[TBL] [Abstract][Full Text] [Related]
11. The relationship of metalloproteinase gene polymorphisms and lung cancer.
Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic value of detection of serum C-reactive protein in the patients with stage I lung cancer].
Xu Y; Li Z; Shen-Tu Y
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):400-3. PubMed ID: 21569644
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
[TBL] [Abstract][Full Text] [Related]
14. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H
Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754
[TBL] [Abstract][Full Text] [Related]
15. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Liu L; Yuan P; Wu C; Zhang X; Wang F; Guo H; Zhong R; Xu Y; Wu J; Yu D; Wu T; Zhang X; Nie S; Miao X; Lin D
Lung Cancer; 2011 Jul; 73(1):110-5. PubMed ID: 21129812
[TBL] [Abstract][Full Text] [Related]
16. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
19. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
